Treatment of HepG2 Cells With Lapatinib

NR Noëmi Johanna Roos
DA Diell Aliu
JB Jamal Bouitbir
SK Stephan Krähenbühl
ask Ask a question
Favorite

We treated HepG2 cells with 2, 5, 10, and 20 µM lapatinib for 2, 6, or 24 h. The stock solutions (1,000X) were prepared in dimethyl sulfoxide (DMSO) and stored at −20°C. Accordingly, we used 0.1% (v/v) DMSO as a negative control treatment.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A